{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:17:19Z","timestamp":1789903039498,"version":"4.0.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2018.00251","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T04:31:31Z","timestamp":1537504291000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer\u2019s Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Chun-Chao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Yi","family":"Jhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"The Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Po","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2008.04.021","article-title":"Default-mode network activity distinguishes amnestic type mild cognitive impairment from healthy aging: a combined structural and resting-state functional MRI study.","volume":"438","author":"Bai","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease.","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/01.wnl.0000271375.37131.04","article-title":"Longitudinal changes of CSF biomarkers in memory clinic patients.","volume":"69","author":"Bouwman","year":"2007","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jalz.2013.12.021","article-title":"Social cognition in Alzheimer\u2019s disease: a separate construct contributing to dependence.","volume":"10","author":"Cosentino","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/01.wnl.0000295996.54210.69","article-title":"Disease-modifying therapies for Alzheimer disease: challenges to early intervention.","volume":"69","author":"Cummings","year":"2007","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose\/poitron-emission tomography (FDG\/PET).","volume":"98","author":"de Leon","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1212\/WNL.0b013e31828ab2c9","article-title":"Screening for predementia AD: time-dependent operating characteristics of episodic memory tests.","volume":"80","author":"Derby","year":"2013","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.neuropsychologia.2007.11.030","article-title":"Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer\u2019s disease: insights from functional MRI studies.","volume":"46","author":"Dickerson","year":"2008","journal-title":"Neuropsychologia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease.","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria.","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease.","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","article-title":"Comparison of analytical platforms for cerebrospinal fluid measures of beta-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.","volume":"68","author":"Fagan","year":"2011","journal-title":"Arch. Neurol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jmri.1880070620","article-title":"Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer\u2019s disease.","volume":"7","author":"Fox","year":"1997","journal-title":"J. Magn. Reson. Imaging"},{"key":"B15","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.0308627101","article-title":"Default-mode network activity distinguishes Alzheimer\u2019s disease from healthy aging: evidence from functional MRI.","volume":"101","author":"Greicius","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuroimage.2009.06.060","article-title":"Accurate and robust brain image alignment using boundary-based registration.","volume":"48","author":"Greve","year":"2009","journal-title":"Neuroimage"},{"key":"B17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0042-6989(99)00235-7","article-title":"Larger effect of aging on the perception of higher-order stimuli.","volume":"40","author":"Habak","year":"2000","journal-title":"Vision Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease.","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2012.00295","article-title":"Resting state networks and consciousness: alterations of multiple resting state network connectivity in physiological, pharmacological, and pathological consciousness States.","volume":"3","author":"Heine","year":"2012","journal-title":"Front. Psychol."},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1097\/00005072-199812000-00009","article-title":"Neuropathological and neuropsychological changes in \u201cnormal\u201d aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.","volume":"57","author":"Hulette","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3233\/JAD-142871","article-title":"Estimating the risk for conversion from mild cognitive impairment to Alzheimer\u2019s disease in an elderly Arab community.","volume":"45","author":"Inzelberg","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade.","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: implications for sequence of pathological events in Alzheimer\u2019s disease.","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"B24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/01.wnl.0000269790.05105.16","article-title":"What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?","volume":"69","author":"Jagust","year":"2007","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"Fsl.","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"key":"B26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","article-title":"A global optimisation method for robust affine registration of brain images.","volume":"5","author":"Jenkinson","year":"2001","journal-title":"Med. Image Anal."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease.","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B28","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.3233\/JAD-2012-120901","article-title":"Visuospatial perception: an emerging biomarker for Alzheimer\u2019s disease.","volume":"31","author":"Mandal","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/535816","article-title":"The default mode network in healthy aging and Alzheimer\u2019s disease.","volume":"2011","author":"Mevel","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"B30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease.","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"B32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201dpreclinical\u201d.","volume":"45","author":"Price","year":"1999","journal-title":"Alzheimers Dis. Ann. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease.","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2176","article-title":"Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.","volume":"6","author":"Shaw","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1148\/radiol.2323030830","article-title":"MR procedures: biologic effects, safety, and patient care.","volume":"232","author":"Shellock","year":"2004","journal-title":"Radiology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13040","DOI":"10.1073\/pnas.0905267106","article-title":"Correspondence of the brain\u2019s functional architecture during activation and rest.","volume":"106","author":"Smith","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B37","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL.","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage"},{"key":"B38","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"(Toward )defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the national institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Sperling","year":"","journal-title":"Alzheimers Dement"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target, and right drug at the right stage.","volume":"3","author":"Sperling","year":"","journal-title":"Sci. Transl."},{"key":"B40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0006-3223(99)00143-2","article-title":"Longitudinal stability of CSF tau levels in Alzheimer patients.","volume":"46","author":"Sunderland","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2967\/jnumed.109.064360","article-title":"Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding.","volume":"50","author":"Tolboom","year":"2009","journal-title":"J. Nucl. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1212\/WNL.0b013e3181af79e5","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.","volume":"73","author":"Vemuri","year":"","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.","volume":"73","author":"Vemuri","year":"","journal-title":"Neurology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/srep14824","article-title":"Aberrant intra- and inter-network connectivity architectures in Alzheimer\u2019s disease and mild cognitive impairment.","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.neuroimage.2008.10.055","article-title":"Bayesian analysis of neuroimaging data in FSL.","volume":"45","author":"Woolrich","year":"2009","journal-title":"Neuroimage"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2018.00251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T04:31:36Z","timestamp":1537504296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2018.00251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":45,"alternative-id":["10.3389\/fnagi.2018.00251"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2018.00251","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,21]]},"article-number":"251"}}